Cargando…

Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive Bladder

OBJECTIVE: To evaluate the effects of tadalafil monotherapy on lower urinary tract symptoms, urodynamic parameters, and oxidative stress levels in male patients. METHODS: This prospective study included 53 male patients with urinary symptoms, who met the criteria for overactive bladder (OAB) (≥ 2 po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuo, Tomohiro, Miyata, Yasuyoshi, Araki, Kyohei, Mukae, Yuta, Otsubo, Asato, Ohba, Kojiro, Sakai, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Asia Pty Ltd 2019
Materias:	Original Articles ‐ Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004155/ https://www.ncbi.nlm.nih.gov/pubmed/31407871 http://dx.doi.org/10.1111/luts.12283

Ejemplares similares

Excessive accumulation of visceral fat is associated with lower urinary symptoms including overactive bladder in female patients
por: Otsubo, Asato, et al.
Publicado: (2020)

Presurgical bladder wall thickness is a useful marker to predict the postsurgical improvement of symptoms in patients with pelvic organ prolapse‐related overactive bladder
por: Otsubo, Asato, et al.
Publicado: (2021)

Efficacy of salt reduction for managing overactive bladder symptoms: a prospective study in patients with excessive daily salt intake
por: Matsuo, Tomohiro, et al.
Publicado: (2021)

Pathological roles of c-Met in bladder cancer: Association with cyclooxygenase-2, heme oxygenase-1, vascular endothelial growth factor-A and programmed death ligand 1
por: Mukae, Yuta, et al.
Publicado: (2020)

Present Status, Limitations and Future Directions of Treatment Strategies Using Fucoidan-Based Therapies in Bladder Cancer
por: Miyata, Yasuyoshi, et al.
Publicado: (2020)

Mechanisms Underlying the Inhibition of Tyrosine Kinase Inhibitor-Induced Anorexia and Fatigue by Royal Jelly in Renal Cell Carcinoma Patients and the Correlation between Macrophage Colony Stimulating Factor and Inflammatory Mediators
por: Yuno, Tsutomu, et al.
Publicado: (2020)

Molecular Mechanisms of the Anti-Cancer Effects of Isothiocyanates from Cruciferous Vegetables in Bladder Cancer
por: Mastuo, Tomhiro, et al.
Publicado: (2020)

Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia
por: Mitsunari, Kensuke, et al.
Publicado: (2021)

Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer
por: Miyata, Yasuyoshi, et al.
Publicado: (2018)

Impact of Mirabegron Administration on the Blood Pressure and Pulse Rate in Patients with Overactive Bladder
por: Ito, Hidenori, et al.
Publicado: (2022)

Relationship between Urinary Calcium Excretion and Lower Urinary Tract Symptoms
por: Matsuo, Tomohiro, et al.
Publicado: (2022)

Pathological significance and prognostic role of LATS2 in prostate cancer
por: Matsuda, Tsuyoshi, et al.
Publicado: (2021)

A Review of Oxidative Stress and Urinary Dysfunction Caused by Bladder Outlet Obstruction and Treatments Using Antioxidants
por: Miyata, Yasuyoshi, et al.
Publicado: (2019)

The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men
por: Matsuo, Tomohiro, et al.
Publicado: (2016)

Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
por: Miyata, Yasuyoshi, et al.
Publicado: (2020)

Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
por: Miyata, Yasuyoshi, et al.
Publicado: (2020)

Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial
por: Araki, Kyohei, et al.
Publicado: (2018)

Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2
por: Araki, Kyohei, et al.
Publicado: (2020)

Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy
por: Matsuo, Tomohiro, et al.
Publicado: (2018)

Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and Photosensitizers
por: Miyata, Yasuyoshi, et al.
Publicado: (2020)

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34
por: Miyata, Yasuyoshi, et al.
Publicado: (2013)

Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model
por: Masato, Masahito, et al.
Publicado: (2021)

High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
por: Miyata, Yasuyoshi, et al.
Publicado: (2013)

Recovery from life-threatening pelvic organ prolapse in an 80-year-old Japanese woman: a case report
por: Matsuo, Tomohiro, et al.
Publicado: (2014)

Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T‐cell leukemia virus type 1‐associated myelopathy: A single‐institution case series
por: Matsuo, Tomohiro, et al.
Publicado: (2021)

A pilot study to assess the safety and usefulness of combined transurethral endoscopic mucosal resection and en-bloc resection for non-muscle invasive bladder cancer
por: Hayashida, Yasushi, et al.
Publicado: (2019)

Left atrial metastasis of renal cell carcinoma: a case report and review of the literature
por: Ohba, Kojiro, et al.
Publicado: (2014)

Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis
por: Miyata, Yasuyoshi, et al.
Publicado: (2017)

Pathological Significance of Macrophages in Erectile Dysfunction Including Peyronie’s Disease
por: Miyata, Yasuyoshi, et al.
Publicado: (2021)

A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study)
por: Yamanishi, Tomonori, et al.
Publicado: (2020)

Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis
por: Miyata, Yasuyoshi, et al.
Publicado: (2012)

Met in Urological Cancers
por: Miyata, Yasuyoshi, et al.
Publicado: (2014)

Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo‐Adjuvant Hormonal Therapy in Prostate Cancer Patients
por: Asai, Akihiro, et al.
Publicado: (2016)

Periodontal Disease in Patients Receiving Dialysis
por: Miyata, Yasuyoshi, et al.
Publicado: (2019)

Pathological Characteristics of Periodontal Disease in Patients with Chronic Kidney Disease and Kidney Transplantation
por: Kitamura, Mineaki, et al.
Publicado: (2019)

The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study
por: Ueda, Yasufumi, et al.
Publicado: (2023)

Neoadjuvant hormonal therapy for low‐risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis‐related parameters
por: Miyata, Yasuyoshi, et al.
Publicado: (2017)

Urodynamic characteristics of lower urinary tract of patients with idiopathic overactive bladder
por: Dekhtiar, Yuriy M., et al.
Publicado: (2019)

Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non‐muscle‐invasive bladder cancer: a randomised clinical trial
por: Miyata, Yasuyoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o92gtis9alq2dse5n02u4n44gv